Back to search

Factors related to intracranial hematoma formation in patients receiving tissue-type plasminogen activator for acute ischemic stroke.

Data up to Jan 2025

Published1994
Citations211
References20

Total Citations Per Year

Abstract

References (20)

Measurements of acute cerebral infarction: a clinical examination scale.

1989 • 5,225 citations

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke

1992 • 992 citations

MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

1990 • 911 citations

In-hospital mortality and clinical course of 20 891 patients with suspected acute myocardial infarction randomised between alteplase and streptokinase with or without heparin

1990 • 612 citations

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes.

1992 • 541 citations

Hemorrhagic Events during Therapy with Recombinant Tissue-Type Plasminogen Activator, Heparin, and Aspirin for Acute Myocardial Infarction

1991 • 472 citations

Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group.

1993 • 420 citations

Hemorrhagic cerebral infarction--a prospective study.

1986 • 333 citations

The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment

1992 • 282 citations

Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke.

1992 • 267 citations

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

1988 • 160 citations

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

1992 • 137 citations

Clinical risks of thrombolytic therapy

1992 • 119 citations

Intracranial hemorrhage after coronary thrombolysis with tissue plasminogen activator

1992 • 94 citations

Intracranial Hemorrhage after Use of Tissue Plasminogen Activator for Coronary Thrombolysis

1990 • 92 citations

Cerebrovascular events after myocardial infarction: analysis of the GISSI trial. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

1991 • 79 citations

Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis

1991 • 65 citations

Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis

1992 • 62 citations

Fatal Streptokinase-Induced Intracerebral Haemorrhage in Cerebral Amyloid Angiopathy

1990 • 36 citations

Intracranial Hemorrhage Following Thrombolytic Therapy for Acute Myocardial Infarction

1991 • 12 citations

Cited By (0)

Loading...
Factors related to intracranial hematoma formation in patients receiving tissue-type… (1994) – Stroke | Metascience Observatory Explorer